Home News News OptoSeeker Joins NVIDIA Inception Program to Build Next-Gen AI Drug Discovery Platform

OptoSeeker Joins NVIDIA Inception Program to Build Next-Gen AI Drug Discovery Platform

2025-12-18

5e68790701091bab35a43c3cfb46d8b3.jpeg
OptoSeeker Biotech is proud to announce that it has officially joined NVIDIA Inception Program, a global program designed to nurture startups that are reinventing industries with cutting-edge technology.

OptoSeeker specializes in pivotal fields including optoelectronic tweezers (OET), microfluidics, antibody discovery, cell therapy, and cell-gene editing. Leveraging its self-developed OptoBot® series of high-throughput single-cell optofluidic sorters, the company has established a full-stack, autonomous platform covering the entire "Screening - Sequencing - Data Analysis" workflow. This platform addresses critical pain points for biopharmaceutical companies by significantly shortening antibody screening cycles and reducing the costs associated with cell and gene therapy (CGT) development.


Furthermore, OptoSeeker is pioneering a future-oriented, AI-driven platform architecture to build the next generation of intelligent infrastructure for macromolecular drug innovation. By optimizing its OptoBot® series and end-to-end intelligent computing frameworks, OptoSeeker is committed to providing higher-efficiency and higher-quality solutions for the global biopharmaceutical industry.


By joining NVIDIA Inception Program,OptoSeeker will receive specialized technical support, including access to the NVIDIA BioNeMo platform and NVIDIA Triton Inference Server. Combined with expert ecosystem empowerment and computing power optimization, this collaboration will enable OptoSeeker to achieve rapid iteration and closed-loop optimization based on large-scale datasets. This marks a critical milestone in the company’s mission to build the next generation of intelligent R&D infrastructure for life sciences. The program will also provide OptoSeeker with opportunities to collaborate with industry-leading experts and other AI-driven organizations.


Dr. Hainan Xie, CEO of OptoSeeker Biotech, stated:

"The digital upgrading and intelligent transformation of the biopharmaceutical industry are core trends in industrial development. NVIDIA’s global leadership in computing power, algorithms, and ecosystem resources provides the essential support for OptoSeeker to overcome technical bottlenecks and expand industrial-scale applications. Through this program, we will not only gain core technical empowerment but also accelerate the landing of our innovations through NVIDIA’s vast ecosystem, bringing more competitive R&D solutions to the global biopharmaceutical sector."


About NVIDIA Inception Program
NVIDIA Inception Program is a global program that helps startups during critical stages of product development, prototyping, and deployment. Every Inception  Program member gets a custom set of ongoing benefits, such as NVIDIA Training credits, preferred pricing on NVIDIA hardware and software, and technological assistance, which provides startups with the fundamental tools to help them grow.